Literature DB >> 35426796

[A long-term ischemic stroke risk score model in patients aged 60 years and older with obstructive sleep apnea: a multicenter prospective cohort study].

X Su1,2, J Han2, Y Gao8, L Fan4, Z He2, Z Zhao1,4, J Lin5, J Guo6, K Chen7, Y Gao8, L Liu1.   

Abstract

OBJECTIVE: To analyze the independent risk factors of long-term ischemic stroke and establish a nomogram for predicting the long-term risks in elderly patients with obstructive sleep apnea (OSA).
METHODS: This multicenter prospective cohort study was conducted from January, 2015 to October, 2017 among consecutive elderly patients (≥60 years) with newly diagnosed OSA without a history of cardio-cerebrovascular diseases and loss of important clinical indicators. The follow-up outcome was the occurrence of ischemic stroke. The baseline demographic and clinical data, sleep parameters, laboratory and ultrasound results were collected from all the patients, who were randomized into the modeling group (n=856) and validation group (n=258) at a 3∶1 ratio. LASSO regression was used for variable reduction and dimension screening, and the risk score prediction model of ischemic stroke was established based on Cox proportional hazard regression.
RESULTS: In the total of 1141 patients enrolled in this study, 58 (5.08%) patients experienced ischemic stroke during the median follow-up of 42 months (range 41-54 months). The cumulative incidence of ischemic stroke was 5.14% in the model group and 4.91% in the verification group (P < 0.05). Age (HR=3.44, 95% CI: 2.38- 7.77), fasting blood glucose (FPG) (HR=2.13, 95% CI: 1.22-3.72), internal diameter of the ascending aorta (HR=2.60, 95% CI: 1.0- 4.47), left atrial anteroposterior diameter (HR=1.98, 95% CI: 1.75-2.25) and minimum oxygen saturation (LSpO2) (HR=1.57, 95% CI: 1.20-1.93) were identified as independent risk factors for ischemic stroke (P < 0.05 or 0.01). A long-term ischemic stroke risk score model was constructed based the regression coefficient ratios of these 5 risk variables. Before and after the application of the Bootstrap method, the AUC of the cohort risk score model was 0.84 (95% CI: 0.78- 0.90) and 0.85 (95% CI: 0.78- 0.89) in the model group and was 0.83 (95% CI: 0.73-0.93) and 0.82 (95%CI: 0.72-0.90) in the verification group, respectively, suggesting a good prediction efficiency and high robustness of the model. At the best clinical cutoff point, the cumulative incidence of ischemic stroke was significantly higher in the high-risk group than in the low-risk group (P=0.021).
CONCLUSION: This model can help to identify high-risk OSA patients for early interventions of the risks of ischemic stroke associated with OSA.

Entities:  

Keywords:  ModeL; elderly; ischemic stroke; obstructive sleep apnea; risk prediction

Mesh:

Year:  2022        PMID: 35426796      PMCID: PMC9010997          DOI: 10.12122/j.issn.1673-4254.2022.03.04

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  28 in total

1.  Obstructive sleep apnea in older adults is a distinctly different physiological phenotype.

Authors:  Bradley A Edwards; Andrew Wellman; Scott A Sands; Robert L Owens; Danny J Eckert; David P White; Atul Malhotra
Journal:  Sleep       Date:  2014-07-01       Impact factor: 5.849

2.  Association of obstructive sleep apnea and cerebral small vessel disease: a systematic review and meta-analysis.

Authors:  Yuhong Huang; Chunsong Yang; Ruozhen Yuan; Ming Liu; Zilong Hao
Journal:  Sleep       Date:  2020-04-15       Impact factor: 5.849

3.  Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke.

Authors:  Paola Mattaliano; Carolina Lombardi; Davide Sangalli; Andrea Faini; Barbara Corrà; Laura Adobbati; Giovanna Branzi; Davide Mariani; Vincenzo Silani; Gianfranco Parati
Journal:  J Hypertens       Date:  2018-06       Impact factor: 4.844

4.  Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness.

Authors:  N Nasr; A Pavy-Le Traon; M Czosnyka; M Tiberge; E Schmidt; V Larrue
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089

5.  Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up.

Authors:  Fredrik Valham; Thomas Mooe; Terje Rabben; Hans Stenlund; Urban Wiklund; Karl A Franklin
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

6.  Impaired cerebrovascular reactivity in obstructive sleep apnea: a case-control study.

Authors:  Laura B Ponsaing; Ulrich Lindberg; Egill Rostrup; Helle K Iversen; Henrik B W Larsson; Poul Jennum
Journal:  Sleep Med       Date:  2017-11-15       Impact factor: 3.492

7.  Variability and Misclassification of Sleep Apnea Severity Based on Multi-Night Testing.

Authors:  Naresh M Punjabi; Susheel Patil; Ciprian Crainiceanu; R Nisha Aurora
Journal:  Chest       Date:  2020-02-17       Impact factor: 9.410

8.  Preconditioning effect on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Young Woo Kim; Gregory J Zipfel; Christopher S Ogilvy; Katie L Pricola; Babu G Welch; Nabeel Shakir; Bhuvic Patel; John F Reavey-Cantwell; Craig R Kelman; Felipe C Albuquerque; M Yashar S Kalani; Brian L Hoh
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

9.  Impact of obstructive sleep apnea complicated with type 2 diabetes on long-term cardiovascular risks and all-cause mortality in elderly patients.

Authors:  Xiaofeng Su; Jian Hua Li; Yinghui Gao; Kaibing Chen; Yan Gao; Jing Jing Guo; Min Shi; Xiao Zou; Weihao Xu; Li Bo Zhao; Huanhuan Wang; Yabin Wang; Juan Liu; Hu Xu; Xiaoxuan Kong; Junling Lin; Xiaoshun Qian; Jiming Han; Lin Liu
Journal:  BMC Geriatr       Date:  2021-09-25       Impact factor: 3.921

Review 10.  Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Yerem Yeghiazarians; Hani Jneid; Jeremy R Tietjens; Susan Redline; Devin L Brown; Nabil El-Sherif; Reena Mehra; Biykem Bozkurt; Chiadi Ericson Ndumele; Virend K Somers
Journal:  Circulation       Date:  2021-06-21       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.